What does ONCOPATH do?

ONCOPATH is a specialist medical practice in Braine-le-Château. Private Limited, started on 21 January 2015, 1 establishment.

What is the address of ONCOPATH?

The registered office of ONCOPATH is located at Rue Edmond Van Volxem(W-B) 13, 1440 Braine-le-Château.

Is ONCOPATH still active?

Yes. According to the CBE (31 October 2026) ONCOPATH is active, legal situation “Normale toestand”, started on 21 January 2015.

Is ONCOPATH registered on Peppol?

Yes, ONCOPATH is registered on the Peppol network with ID 0208:0568915292.

What is the enterprise number of ONCOPATH?

The enterprise number of ONCOPATH is BE0568915292.

When was ONCOPATH founded?

ONCOPATH was founded on 21 January 2015.

Who are the directors of ONCOPATH?

According to the 2025 annual accounts, the directors of ONCOPATH are: DANIEL FAVERLY.

Is ONCOPATH a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 21 January 2015; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did ONCOPATH make in 2025?

ONCOPATH posted a profit after taxes of € 85,312 in financial year 2025.

What is the revenue of ONCOPATH?

As a small company, ONCOPATH is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 164,263.

ONCOPATH (Private Limited) - Braine-le-Château

Dossier ONCOPATH, printed on 31 October 2026 from databakkes.be/en/0568915292/oncopath. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

ONCOPATH from Braine-le-Château, company number BE0568915292, closed financial year 2025 with a result of € 85,312 after tax. For that financial year ONCOPATH recorded a gross margin of € 164,263 and equity of € 197,897. Compared with financial year 2024, the result moved from € 19,388 to € 85,312. Profitable, and profit is growing. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on October 14, 2026.

What it is worth Healthy

€ 197,897

▼ 2% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 85,312

▲ € 65,924 vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 71

▼ 51% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 88,500 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Wage cost

€ 393

▼ 75% vs 2024

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 3,765

▼ 71% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

€ 46,138

▼ 38% vs 2024

Loans from banks and other lenders, long and short.

Owed to suppliers

€ 5,591

▼ 3% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 44,729

▲ € 33,754 vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Revenue	€ 319,124 Revenue 2022: € 319,124 First fiscal year in the series	€ 226,778 Revenue 2023: € 226,778 ▼ 29% vs 2022 (€ 319,124) Unfavourable step	-	-
Gross margin	€ 131,801 Gross margin 2022: € 131,801 First fiscal year in the series	€ 70,971 Gross margin 2023: € 70,971 ▼ 46% vs 2022 (€ 131,801) Unfavourable step	€ 93,888 Gross margin 2024: € 93,888 ▲ 32% vs 2023 (€ 70,971) Favourable step	€ 164,263 Gross margin 2025: € 164,263 ▲ 75% vs 2024 (€ 93,888) Favourable step	▲ 75%
Profit after taxes	€ 21,766 Profit after taxes 2022: € 21,766 First fiscal year in the series	€ -29,214 Profit after taxes 2023: € -29,214 ▼ € 50,981 vs 2022 (€ 21,766) Unfavourable step	€ 19,388 Profit after taxes 2024: € 19,388 ▲ € 48,602 vs 2023 (€ -29,214) Favourable step	€ 85,312 Profit after taxes 2025: € 85,312 ▲ € 65,924 vs 2024 (€ 19,388) Favourable step	▲ € 65,924
Equity	€ 210,912 Equity 2022: € 210,912 First fiscal year in the series	€ 181,697 Equity 2023: € 181,697 ▼ 14% vs 2022 (€ 210,912) Unfavourable step	€ 201,085 Equity 2024: € 201,085 ▲ 11% vs 2023 (€ 181,697) Favourable step	€ 197,897 Equity 2025: € 197,897 ▼ 2% vs 2024 (€ 201,085) Unfavourable step	▼ 2%
Total debts	€ 210,200 Total debts 2022: € 210,200 First fiscal year in the series	€ 181,236 Total debts 2023: € 181,236 ▼ 14% vs 2022 (€ 210,200) Favourable step	€ 126,558 Total debts 2024: € 126,558 ▼ 30% vs 2023 (€ 181,236) Favourable step	€ 220,958 Total debts 2025: € 220,958 ▲ 75% vs 2024 (€ 126,558) Unfavourable step	▲ 75%
Cash	€ 85 Cash 2022: € 85 First fiscal year in the series	€ 11 Cash 2023: € 11 ▼ 87% vs 2022 (€ 85) Unfavourable step	€ 145 Cash 2024: € 145 ▲ € 134 vs 2023 (€ 11) Favourable step	€ 71 Cash 2025: € 71 ▼ 51% vs 2024 (€ 145) Unfavourable step	▼ 51%
Retained profit	€ 192,312 Retained profit 2022: € 192,312 First fiscal year in the series	€ 163,097 Retained profit 2023: € 163,097 ▼ 15% vs 2022 (€ 192,312) Unfavourable step	€ 182,485 Retained profit 2024: € 182,485 ▲ 12% vs 2023 (€ 163,097) Favourable step	€ 179,297 Retained profit 2025: € 179,297 ▼ 2% vs 2024 (€ 182,485) Unfavourable step	▼ 2%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 0 Dividend 2024: € 0 Unchanged (€ 0) Unchanged	€ 88,500 Dividend 2025: € 88,500 Unchanged (€ 0) Unchanged
Bank debt	€ 182,077 Bank debt 2022: € 182,077 First fiscal year in the series	€ 124,877 Bank debt 2023: € 124,877 ▼ 31% vs 2022 (€ 182,077) Favourable step	€ 73,845 Bank debt 2024: € 73,845 ▼ 41% vs 2023 (€ 124,877) Favourable step	€ 46,138 Bank debt 2025: € 46,138 ▼ 38% vs 2024 (€ 73,845) Favourable step	▼ 38%
Balance sheet total	€ 421,112 Balance sheet total 2022: € 421,112 First fiscal year in the series	€ 362,933 Balance sheet total 2023: € 362,933 ▼ 14% vs 2022 (€ 421,112) Unchanged	€ 327,642 Balance sheet total 2024: € 327,642 ▼ 10% vs 2023 (€ 362,933) Unchanged	€ 418,854 Balance sheet total 2025: € 418,854 ▲ 28% vs 2024 (€ 327,642) Unchanged	▲ 28%

Key figures of ONCOPATH, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to ONCOPATH?

What happened at ONCOPATH in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Oct 14, 2026 New annual accounts for financial year 2025: profit of € 85,312 (▲ € 65,924 vs 2024). filed late Source: NBB ↗
Apr 22, 2015 New establishment in Braine-le-Château. KBO
Jan 21, 2015 Start of the company according to the CBE. KBO

In short

From € 21,766 profit in 2022 to € 85,312 profit in 2025.

Paid € 50,026 in corporate taxes since 2022.

Best year ever: 2025, with € 85,312 profit.

Paid out € 88,500 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

DANIEL FAVERLY

ONCOPATH

HOUSING 58

Behind ONCOPATH is DANIEL FAVERLY. DANIEL FAVERLY is also behind HOUSING 58.

Directors

According to the 2025 annual accounts

DANIEL FAVERLY

Director

Also active at: HOUSING 58

Establishments

Establishment units

Physical locations of this company

Registered office

Rue Edmond Van Volxem(W-B) 13

1440 Braine-le-Château

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.

All companies at this address →

HOUSING 58 same network

€ 57,971 gross margin · 2025

DVVCD

€ 87,200 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0568.915.292

VAT number

BE 0568.915.292

Registered office

Rue Edmond Van Volxem(W-B) 13, 1440 Braine-le-Château

Names & denominations

ONCOPATH

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

21 January 2015

Peppol

Active · Active since 27 Apr 2026

Contact

[email protected]

Activities · NACE

Activiteiten van medisch specialisten

Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied

Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies

Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering

Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied

View on CBE Public ↗ Annual accounts (NBB) ↗

ONCOPATH

Financials

What happened to ONCOPATH?

Management

Directors

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions